Showing results (21-30 of 43) with videos related to
Sort By:
Pageof 5
European Journal of Cancer (Oxford, England : 1990)|November 21, 2017
Outcomes from ovarian cancer screening in the PLCO trial: Histologic heterogeneity impacts detection, overdiagnosis and survivalSarah M Temkin, Eric A Miller, Goli Samimi, et al.Gastrointestinal Endoscopy|January 8, 2008
The natural history of aberrant crypt fociRobert E Schoen, Matthew Mutch, Christopher Rall, et al.Gastrointestinal Endoscopy|June 23, 2009
Reliability and accuracy of the endoscopic appearance in the identification of aberrant crypt fociAkshay K Gupta, Paul Pinsky, Christopher Rall, et al.European Radiology|June 16, 2017
The relationship of cancer characteristics and patient outcome with time to lung cancer diagnosis after an abnormal screening CTSushilkumar K Sonavane, Paul Pinsky, Jubal Watts, et al.Radiology|January 21, 2011
Evaluation of reader variability in the interpretation of follow-up CT scans at lung cancer screeningSatinder Singh, Paul Pinsky, Naomi S Fineberg, et al.Journal of Thoracic Imaging|May 26, 2012
Reader variability in identifying pulmonary nodules on chest radiographs from the national lung screening trialSatinder P Singh, David S Gierada, Paul Pinsky, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 7, 2004
Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma riskUlrike Peters, Richard B Hayes, Nilanjan Chatterjee, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 21, 2005
GSTM1, GSTT1, and GSTP1 polymorphisms and risk of advanced colorectal adenomaLee E Moore, Wen-Yi Huang, Nilanjan Chatterjee, et al.JAMA Internal Medicine|December 11, 2013
Overdiagnosis in low-dose computed tomography screening for lung cancerEdward F Patz, Paul Pinsky, Constantine Gatsonis, et al.Journal of the National Cancer Institute|December 2, 2022
Study design considerations for trials to evaluate multicancer early detection assays for clinical utilityLori M Minasian, Paul Pinsky, Hormuzd A Katki, et al.Pageof 5